Skip to main content
Bioeconomy SA Portal
Bioeconomy SA Portal

National

Zimasa
Innovation

A South African biotech company that manufactures disinfectants with 99.987% efficacy against SARS-CoV-2 (Covid-19) has received approval from European Union (EU).

Zimasa
Cross-Sectorial

The South African Health Products Regulatory Authority on Saturday approved Sinovac for use in South Africa, subject to certain conditions, including that Sinovac has to submit results of clinical

Zimasa
Innovation

The African Union Development Agency (AUDA-NEPAD), in partnership with the Council for Scientific and Industrial Research (CSIR) and Stellenbosch University (SU), have launched a Centre of Excellen

Zimasa
Health

The COVID-19 Pandemic has brought with it many challenges worldwide; one of which is the abundance of misinformation and incorrect public opinion about the virus and the vaccines.